Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Contieri

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
World Journal of Urology|April 3, 2021
Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experienceNicola Frego, Alberto Saita, Paolo Casale, et al.
Frontiers in Oncology|June 6, 2022
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective TrialRoberto Contieri, Giovanni Lughezzani, Nicolò Maria Buffi, et al.
Urologic Oncology|December 3, 2020
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failureRodolfo Hurle, Roberto Contieri, Paolo Casale, et al.
Journal of Clinical Medicine|November 9, 2024
Staging Accuracy and Prognostic Value of Prostate-Specific Membrane Antigen PET/CT Strongly Depends on Lymph Node Tumor BurdenOktay Özman, Hans Veerman, Roberto Contieri, et al.
Urologic Oncology|November 26, 2024
The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysisStefano Moretto, Andrea Piccolini, Andrea Gallioli, et al.
The Canadian Journal of Urology|March 9, 2026
Initial case series and perioperative outcomes of single-port robotic radical prostatectomy: the Italian experienceGianluca Spena, Francesco Passaro, Achille Aveta, et al.
European Urology Oncology|August 9, 2023
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical CystectomyRoberto Contieri, Patrick J Hensley, Wei Shen Tan, et al.
European Urology Open Science|July 13, 2023
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival OutcomesWei Shen Tan, Valentina Grajales, Roberto Contieri, et al.
European Urology Open Science|September 27, 2024
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder TumorAlessandro Uleri, Roberto Contieri, Stefano Moretto, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder CancerAkshay Sood, Alberto Martini, Jan K Rudzinski, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
World Journal of Urology|April 3, 2021
Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experienceNicola Frego, Alberto Saita, Paolo Casale, et al.
Frontiers in Oncology|June 6, 2022
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective TrialRoberto Contieri, Giovanni Lughezzani, Nicolò Maria Buffi, et al.
Urologic Oncology|December 3, 2020
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failureRodolfo Hurle, Roberto Contieri, Paolo Casale, et al.
Journal of Clinical Medicine|November 9, 2024
Staging Accuracy and Prognostic Value of Prostate-Specific Membrane Antigen PET/CT Strongly Depends on Lymph Node Tumor BurdenOktay Özman, Hans Veerman, Roberto Contieri, et al.
Urologic Oncology|November 26, 2024
The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysisStefano Moretto, Andrea Piccolini, Andrea Gallioli, et al.
The Canadian Journal of Urology|March 9, 2026
Initial case series and perioperative outcomes of single-port robotic radical prostatectomy: the Italian experienceGianluca Spena, Francesco Passaro, Achille Aveta, et al.
European Urology Oncology|August 9, 2023
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical CystectomyRoberto Contieri, Patrick J Hensley, Wei Shen Tan, et al.
European Urology Open Science|July 13, 2023
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival OutcomesWei Shen Tan, Valentina Grajales, Roberto Contieri, et al.
European Urology Open Science|September 27, 2024
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder TumorAlessandro Uleri, Roberto Contieri, Stefano Moretto, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder CancerAkshay Sood, Alberto Martini, Jan K Rudzinski, et al.
Pageof 14